Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study (BMC Pulmonary Medicine, (2021), 21, 1, (165), 10.1186/s12890-021-01530-6)

Research output: Contribution to journalComment/debatepeer-review

Abstract

Following publication of the original article [1], it was brought to our attention that panel ‘e’ was missing from Fig. 2; the figure has since been corrected in the published article. (Figure presented.).

Original languageEnglish
Article number193
JournalBMC Pulmonary Medicine
Volume21
Issue number1
DOIs
Publication statusPublished - 2021 Dec

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study (BMC Pulmonary Medicine, (2021), 21, 1, (165), 10.1186/s12890-021-01530-6)'. Together they form a unique fingerprint.

Cite this